Business
Evolus to Participate in 2025 Stifel Healthcare Conference
NEWPORT BEACH, Calif., October 28, 2025--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Stifel Healthcare Conference.
About this update from Evolus, Inc. Common Stock
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/31d6af72a4684e7ef0419407f10a99c6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/F2.qEUmwucYJ5b9m74J5BQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/31d6af72a4684e7ef0419407f10a99c6","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/di7qvqS0.8WqJSMHL6yIOw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/31d6af72a4684e7ef0419407f10a99c6","width":1024,"height":512}},"lazy":false},{"type":"text","content":"NEWPORT BEACH, Calif., October 28, 2025--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Stifel Healthcare Conference.","length":334,"tagName":"p"},{"type":"text","content":"The fireside chat will take place on Tuesday, November 11, 2025, at 11:20 AM ET.","length":80,"tagName":"p"},{"type":"text","content":"The fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will be available 90 days after the date of the presentation.","length":178,"tagName":"p"},{"type":"text","content":"About Evolus, Inc.","length":18,"tagName":"p"},{"type":"text","content":"Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.","length":582,"tagName":"p"},{"type":"text","content":"Jeuveau® and Nuceiva®, are registered trademarks and Evolysse™ is a trademark of Evolus, Inc.","length":93,"tagName":"p"},{"type":"text","content":"View sou...